Marc Ferrante (An Outtier)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Ulcerative Colitis

Ejection Fraction

Top Venues

CPT: pharmacometrics & systems pharmacology

Inflammatory bowel diseases

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

An Outtier, Liese Gijbels, Maja Noman, Bram Verstockt, João Sabino, Séverine Vermeire, Marc Ferrante
Screening Failure in a Large Clinical Trial Centre for Inflammatory Bowel Diseases: Rates, Causes, and Outcomes. Inflammatory bowel diseases (2022)
Wannee Kantasiripitak, Marc Ferrante, Sebastian Georg Wicha, Alexander Kensert, Zhigang Wang, João Sabino, Severine Vermeire, Debby Thomas, Marc Ferrante, Erwin Dreesen
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases. CPT: pharmacometrics & systems pharmacology 11 (8) (2022)
Bram Verstockt, Valery Volk, Charlot Jaeckel, Dahham Alsoud, João Sabino, Susanna Nikolaus, Marc Ferrante, Nicole Krönke, Friedrich Feuerhake, Gert De Hertogh, Philip Rosenstiel, Séverine Vermeire, Stefan Schreiber, Marc Ferrante, Konrad Aden
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis. Alimentary pharmacology & therapeutics 56 (2) (2022)